• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯并吗啡烷骨架在阿片类镇痛药和药理学工具开发中的应用:全面综述。

Benzomorphan scaffold for opioid analgesics and pharmacological tools development: A comprehensive review.

机构信息

Department of Drug Sciences, Medicinal Chemistry Section, University of Catania, Viale A. Doria, 6, 95100, Catania, Italy.

Department of Drug Sciences, Medicinal Chemistry Section, University of Catania, Viale A. Doria, 6, 95100, Catania, Italy.

出版信息

Eur J Med Chem. 2018 Mar 25;148:410-422. doi: 10.1016/j.ejmech.2018.02.046. Epub 2018 Feb 17.

DOI:10.1016/j.ejmech.2018.02.046
PMID:29477074
Abstract

Benzomorphan, derived by morphine skeleton simplification, has been the subject of exploration in medicinal chemistry for the development of new drugs and pharmacological tools to explore opioid pharmacology in vitro and in vivo. Building upon these evidences, the design and synthesis of benzomorphan-based compounds, appropriately modified at the basic nitrogen and/or the phenolic hydroxyl (8-OH) group, represent a valid and versatile strategy to obtain analgesics. In this review, to improve the body of information in this field, we report structure activity-relationships (SARs) of benzomorphan-based compounds analysing data literature of last 25 years. Collectively, SARs data highlighted that the benzomorphan nucleus represents a template in the achievement of a specific functional profile, by modifying N-substituent or 8-OH group.

摘要

苯并吗啡烷通过吗啡骨架简化衍生而来,一直是药物化学领域探索的对象,目的是开发新药和药理学工具,以在体外和体内探索阿片类药物的药理学。在此基础上,对基本氮原子和/或酚羟基(8-OH)基团进行适当修饰的苯并吗啡烷类化合物的设计和合成,代表了获得镇痛药的一种有效且通用的策略。在这篇综述中,为了改进该领域的信息,我们报告了苯并吗啡烷类化合物的构效关系(SAR),分析了过去 25 年的文献数据。总的来说,SAR 数据表明,苯并吗啡烷核是通过修饰 N-取代基或 8-OH 基团来实现特定功能特性的模板。

相似文献

1
Benzomorphan scaffold for opioid analgesics and pharmacological tools development: A comprehensive review.苯并吗啡烷骨架在阿片类镇痛药和药理学工具开发中的应用:全面综述。
Eur J Med Chem. 2018 Mar 25;148:410-422. doi: 10.1016/j.ejmech.2018.02.046. Epub 2018 Feb 17.
2
Benzomorphan skeleton, a versatile scaffold for different targets: A comprehensive review.苯并吗啡烷骨架,适用于不同靶点的多功能支架:全面综述。
Eur J Med Chem. 2018 Jul 15;155:492-502. doi: 10.1016/j.ejmech.2018.06.017. Epub 2018 Jun 7.
3
Evaluation of N-substitution in 6,7-benzomorphan compounds.6,7-苯并吗啡烷类化合物 N-取代基的评价。
Bioorg Med Chem. 2010 Jul 15;18(14):4975-82. doi: 10.1016/j.bmc.2010.06.005. Epub 2010 Jun 9.
4
Evaluation of N-substituent structural variations in opioid receptor profile of LP1.LP1阿片受体谱中N-取代基结构变异的评估。
Bioorg Med Chem. 2016 Jun 15;24(12):2832-42. doi: 10.1016/j.bmc.2016.05.005. Epub 2016 May 5.
5
(2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist.(2S)-N-2-甲氧基-2-苯乙基-6,7-苯并吗啡烷化合物(2S-LP2):一种偏向性 μ/δ 阿片受体激动剂的发现。
Eur J Med Chem. 2019 Apr 15;168:189-198. doi: 10.1016/j.ejmech.2019.02.043. Epub 2019 Feb 18.
6
Development of novel LP1-based analogues with enhanced delta opioid receptor profile.具有增强的δ阿片受体特征的新型基于LP1的类似物的开发。
Bioorg Med Chem. 2017 Sep 1;25(17):4745-4752. doi: 10.1016/j.bmc.2017.07.021. Epub 2017 Jul 11.
7
New benzomorphan derivatives of MPCB as MOP and KOP receptor ligands.作为μ-阿片受体(MOP)和κ-阿片受体(KOP)配体的新型MPCB苯并吗啡烷衍生物。
Pharmazie. 2007 Nov;62(11):813-24.
8
Design, synthesis, in vitro evaluation, and molecular modeling studies of N-substituted benzomorphans, analogs of LP2, as novel MOR ligands.设计、合成、体外评价和分子模拟研究 N-取代苯并吗啡烷类化合物,作为新型 MOR 配体的 LP2 类似物。
Chem Biol Drug Des. 2023 Jun;101(6):1382-1392. doi: 10.1111/cbdd.14220. Epub 2023 Mar 5.
9
Synthesis and pharmacology of 8-amino-3-[(tetrahydro-2-furanyl)methyl] benzomorphan.8-氨基-3-[(四氢-2-呋喃基)甲基]苯并吗啡烷的合成与药理学
Yao Xue Xue Bao. 2003 Oct;38(10):748-53.
10
Synthesis and Structure-Activity Relationships of LP1 Derivatives: N-Methyl-N-phenylethylamino Analogues as Novel MOR Agonists.LP1 衍生物的合成及构效关系研究:N-甲基-N-苯乙基氨基类似物作为新型 MOR 激动剂。
Molecules. 2018 Mar 16;23(3):677. doi: 10.3390/molecules23030677.

引用本文的文献

1
N-(3-Hydroxyphenyl)-3,8-diazabicyclooctanes as opioid receptors probes. 1. Investigation of the phenolic hydroxyl group.N-(3-羟基苯基)-3,8-二氮杂双环辛烷作为阿片受体探针。1. 酚羟基的研究。
Eur J Med Chem. 2025 Nov 15;298:117991. doi: 10.1016/j.ejmech.2025.117991. Epub 2025 Jul 23.
2
Quinoline conjugates for enhanced antimalarial activity: a review on synthesis by molecular hybridization and structure-activity relationship (SAR) investigation.用于增强抗疟活性的喹啉缀合物:分子杂交合成及构效关系(SAR)研究综述
Am J Transl Res. 2025 Feb 15;17(2):1335-1375. doi: 10.62347/TTHX6526. eCollection 2025.
3
Design, Synthesis, and Evaluation of Novel (-)-cis-N-Normetazocine Derivatives: In Vitro and Molecular Modeling Insights.
新型(-)-顺式-N-去甲左啡诺衍生物的设计、合成与评价:体外及分子模拟研究
Chem Biol Drug Des. 2024 Dec;104(6):e70037. doi: 10.1111/cbdd.70037.
4
New Insights into the Opioid Analgesic Profile of -(-)--Normetazocine-derived Ligands.新型-(-)--去甲左啡诺衍生配体的阿片类镇痛药特性的新见解。
Molecules. 2023 Jun 17;28(12):4827. doi: 10.3390/molecules28124827.
5
LP1 and LP2: Dual-Target MOPr/DOPr Ligands as Drug Candidates for Persistent Pain Relief.LP1 和 LP2:作为治疗持续性疼痛候选药物的双重靶向 MOPr/DOPr 配体。
Molecules. 2021 Jul 8;26(14):4168. doi: 10.3390/molecules26144168.
6
Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands.κ 阿片受体配体和药理学:二苯乙基胺,一类结构独特、选择性 κ 阿片受体配体。
Handb Exp Pharmacol. 2022;271:163-195. doi: 10.1007/164_2020_431.
7
Development of Diphenethylamines as Selective Kappa Opioid Receptor Ligands and Their Pharmacological Activities.二苯乙基胺类化合物作为选择性 κ 阿片受体配体的发展及其药理学活性。
Molecules. 2020 Nov 2;25(21):5092. doi: 10.3390/molecules25215092.
8
Novel -Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists.新型取代苯并吗啡烷类化合物:从MOR激动剂/DOR拮抗剂到偏向/非偏向MOR激动剂
ACS Med Chem Lett. 2020 Jan 28;11(5):678-685. doi: 10.1021/acsmedchemlett.9b00549. eCollection 2020 May 14.
9
Determination of structural factors affecting binding to mu, kappa and delta opioid receptors.测定影响与μ、κ和δ阿片受体结合的结构因素。
Arch Toxicol. 2020 Apr;94(4):1215-1227. doi: 10.1007/s00204-020-02684-8. Epub 2020 Feb 27.
10
Synthesis and Structure-Activity Relationships of (-)---Normetazocine-Based LP1 Derivatives.基于(-)-去甲美他佐辛的LP1衍生物的合成及其构效关系
Pharmaceuticals (Basel). 2018 May 5;11(2):40. doi: 10.3390/ph11020040.